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Abstract
Beta-lactam antibiotics, e.g. penicillin, may inhibit platelet function and lead to reduced response in light transmis-
sion aggregometry and adhesion. However, influence on platelet function tests more commonly used in clinical
practice, such as multiple electrode platelet aggregometry (MEA), have not been described so far. We report a case
of a patient with local streptococcus infection. Treatment with penicillin resulted in mild bleeding tendency after
3 days. While coagulation parameters were normal, assessment of platelet function by MEA revealed strong platelet
inhibition of both ADP and arachidonic acid induced platelet aggregation comparable to normal responders to
antiplatelet therapy. Change of antibiotic regime resulted in recovery of platelet function. Thus, penicillin therapy
may impact on platelet function and consecutively commonly used platelet function assays, e.g. MEA.
Case report
Inhibition of platelet function in the presence of beta-lac-
tam antibiotics was first described decades ago. In the
first documented report in 1973, Cazenave et al. found
that beta-lactam antibiotics (BLA), e.g. penicillin, inhibit
all major types of platelet functions in vitro, such as
secretion, adhesion and also aggregation [1]. Postulated
mechanisms are inhibition of agonist-stimulated platelet
calcium influx [2], and impairment of agonist binding to
their specific receptors on the platelet surface [3]. Impor-
tantly, penicillin binds irreversibly to platelets [4]. This
results in a dose- and time-dependent effect of BLA on
platelet function in animals and humans, which occurs
within 24 to 72 hours after therapy induction [4-6].
A 46-year old female patient presented to our clinic
with a perimandibular abscess following surgical
removal of a third molar. The patient had no medical
therapy upon admission. Despite elevated inflammation
parameters other blood tests were normal. The patient
was treated with surgical drainage and intravenous peni-
cillin (12 million IU/day) because of local infection with
penicillin-sensitive streptococcus species. Due to swel-
ling of the neck and jaw the patient required mechanical
ventilation for three days. In addition to antibiotic ther-
apy, the patient received fentanyl and midazolam intra-
venously for analgo-sedation, and enteral feeding by
tube.
On postoperative day 3 bleeding tendency during
invasive procedure (routine placement of arterial
catheter) was noticed. Platelet counts (174000 [150000-
450000]/μl), partial thromboplastin time (PTT 31
[25-39] sec) and international normalized ratio (INR
1.0) were normal. However, multiple electrode platelet
aggregometry (MEA)[7] revealed significant inhibition in
platelet function in both adenosine diphosphate (ADP)
and arachidonic acid (AA) tests (fig. 1). In detail, on day
3 MEA area under the curve (AUC) in response to ADP
was 250, and 109 in response to AA respectively. In a
recent study, MEA results from untreated and clopido-
grel naïve subjects were 650.5 AUC [523.0-807.0] at
baseline, and application of 600 mg of clopidogrel
resulted in a significant reduction to 233.5 AUC [145.0-
429.5][8]. Likewise, intravenous application of 500 mg
acetylsalicylic acid resulted in mean values of arachido-
nic acid-induced aggregation (ASPI test) of 137 ± 44 [9].
Thus, the here presented inhibition of ADP- and AA-
induced platelet aggregation in the presence of BLA is
similar to patients receiving antiplatelet therapy (fig. 1).
Next, the antibiotic regime was changed to clinda-
mycin and ciprofloxacin. After cessation of penicillin
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treatment, platelet MEA response increased (fig. 1).
However, ADP-induced platelet aggregation was still
abnormal 4 days after application of the last penicillin
dose. Thus, penicillin treatment may lead to significant
platelet inhibition, and normalization of platelet function
is prolonged due to irreversible binding of penicillin to
platelets [4]. Importantly, recovery of platelet function
after discontinuation of treatment in vivo normally
requires 3 to 7 days [6]. However, cases with abnormal
aggregation for more than 2 weeks after cessation of
penicillin therapy have been described [6].
In the era of coronary stent placement platelet func-
tion assays are widely used to assess platelet function
under antiplatelet therapy. MEA is a common test to
determine platelet reactivity under treatment with clopi-
dogrel and acetylsalicylic acid, and results closely corre-
late with light transmission aggregometry [8]. MEA
seems to be superior to other platelet function tests, e.g.
VASP assay, in the prediction of adverse events such as
stent thrombosis [10].
However, patients undergoing percutaneous coronary
intervention (PCI) may develop infections of any kind
that require medical treatment. Antibiotics are widely
prescribed drugs for both in- and outpatient use [11,12].
It is, therefore, tempting to speculate that simultaneous
application of antiplatelet drugs and beta-lactam
antibiotics leads to significant variations in MEA values.
In worst-case scenario, insufficient response to antiplate-
let drugs, e.g. clopidogrel, may be disguised by the effect
of BLA. Whether a combined treatment with beta-lac-
tam antibiotics and antiplatelet drugs impacts on
hemostasis, and whether the validity of commonly used
platelet reactivity tests is influenced by BLA should be
clarified by future studies. Also, it should be addressed
if antiplatelet therapy in individuals with penicillin as a
co-medication leads to increased bleeding events, and if
in these patients antiplatelet therapy needs to be (tem-
porarily) reduced.
While impairment of platelet function in vivo seems
to be a rather common phenomenon in individuals
receiving penicillin and also other BLA [4-6,13], occur-
rence of bleeding secondary to platelet dysfunction may
vary [13]. These differences can be attributed to dose-
dependent effects of penicillin and a consequence of
irreversible binding to platelets [4-6], but also to the
type of BLA chosen for treatment [13]. Further, blood
serum constituents, e.g. albumin, may influence occur-
rence of bleeding in patients receiving BLA [14].
In summary, the here described case report suggests
that patients under BLA therapy may display disturbed
platelet function. As in our case, platelet inhibition can
result in a significantly reduced aggregatory response to
Figure 1 Trend in platelet function in relation to penicillin therapy. Platelet function was assessed by multiple electrode platelet
aggregometry (AUC) in response to adenosine diphosphate (ADP) and arachidonic acid (AA). Intravenous penicillin therapy (12 million IU/day)
was discontinued after 3 days of treatment. Colored lines indicate AUC mean values from human subjects in previous studies in response to
either ADP (yellow) at baseline (naïve) and after receiving 600 mg clopidogrel [8], or AA (blue) before and after application of 500 mg
acetylsalicylic acid (ASA) [9]. In the presence of penicillin, aggregatory response to ADP and AA was inhibited and MEA values were similar to
normal responders to antiplatelet therapy.
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ADP and AA comparable to normal responders to anti-
platelet therapy [15]. Therefore, in some cases it may be
indicated to re-evaluate platelet function after disconti-
nuation of BLA treatment.
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